首页 › 股票 › SLRN

SLRN — ACELYRIN INC

申报持仓市值$342.97M
持有基金数(最新)222
板块—

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

HoldingsHub 追踪了 SLRN(ACELYRIN INC)近五年的季度 13F 申报数据。历史上有 222 家基金申报过持仓,其最近一期申报市值合计 $342.97M。最新季度无机构披露持仓,通常意味着该股已退出追踪基金的组合,而非不可投资。

ACELYRIN INC(SLRN)的主要机构持有人包括 TANG CAPITAL MANAGEMENT LLC、AyurMaya Capital Management Company, LP、BlackRock Inc,按 13F 申报市值在本页 222 家持有人中排名居前。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q2 2025 2 285 $704 —
Q1 2025 109 71.90M $177.51M -30.5%
Q4 2024 124 86.09M $270.40M +1.3%
Q3 2024 120 83.48M $411.54M -0.3%
Q2 2024 107 75.76M $334.01M -2.1%
Q1 2024 103 78.70M $531.08M +1.0%
Q4 2023 98 70.35M $524.85M +3.1%
Q3 2023 98 66.97M $674.66M -14.2%

表内 8 个季度中,机构持股合计减少 100%(Q3 2023 → Q2 2025);单季变动最大的是 Q1 2025(-30.5%)。

前 25 大机构持仓人(Q2 2025) — 2 家基金

基金股数金额组合权重变化
OSAIC HOLDINGS, INC. 282 $697 0.00% 新进
IFP Advisors, Inc 3 $7 0.00% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q1 2025 — 25 家基金

基金股数金额组合权重变化
TANG CAPITAL MANAGEMENT LLC 9.82M $24.25M 1.34% 新进
AyurMaya Capital Management Company, LP 9.33M $23.06M 26.08% 持有
BlackRock Inc 5.81M $14.34M 0.00% 减持
T. Rowe Price Investment Management, Inc. 4.65M $11.49M 0.01% 减持
Madison Avenue Partners, LP 4.14M $10.23M 0.87% 新进
Vanguard Group 4.08M $10.08M 0.00% 持有
ORBIMED ADVISORS LLC 4.00M $9.88M 0.24% 持有
venBio Partners LLC 3.81M $9.40M 7.61% 持有
Velan Capital Investment Management LP 3.37M $8.32M 8.55% 新进
GENERAL ATLANTIC, L.P. 2.70M $6.66M 0.22% 持有
Samsara BioCapital, LLC 2.52M $6.23M 1.11% 持有
Palo Alto Investors LP 1.79M $4.43M 0.84% 持有
Geode Capital Management 1.77M $4.38M 0.00% 增持
Opaleye Management Inc. 1.61M $3.99M 0.90% 减持
STATE STREET CORP 1.42M $3.51M 0.00% 减持
Balyasny Asset Management 1.31M $3.22M 0.01% 新进
Alyeska Investment Group, L.P. 615.88K $1.52M 0.01% 减持
Renaissance Technologies 599.80K $1.48M 0.00% 增持
Northern Trust Corp 598.15K $1.48M 0.00% 减持
JPMorgan Chase & Co 590.85K $1.46M 0.00% 减持
CANTOR FITZGERALD, L. P. 588.66K $1.45M 0.14% 新进
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 544.58K $1.35M 0.00% 减持
Charles Schwab Investment Management 544.58K $1.35M 0.00% 减持
TOWERVIEW LLC 540.00K $1.33M 0.96% 新进
Goldman Sachs Group 351.41K $867.98K 0.00% 减持

Q4 2024 — 25 家基金

基金股数金额组合权重变化
T. Rowe Price Investment Management, Inc. 12.87M $40.42M 0.03% 增持
AyurMaya Capital Management Company, LP 9.33M $29.31M 25.94% 持有
BlackRock Inc 6.02M $18.91M 0.00% 增持
MILLENNIUM MANAGEMENT LLC 4.71M $14.80M 0.03% 减持
Millennium Management 4.71M $14.80M 0.01% 减持
Vanguard Group 4.08M $12.81M 0.00% 持有
ORBIMED ADVISORS LLC 4.00M $12.57M 0.27% 持有
venBio Partners LLC 3.81M $11.95M 7.00% 减持
Blue Owl Capital Holdings LP 2.78M $8.74M 2.01% 持有
GENERAL ATLANTIC, L.P. 2.70M $8.46M 0.30% 减持
Samsara BioCapital, LLC 2.52M $7.92M 1.09% 持有
Morgan Stanley 2.32M $7.30M 0.00% 增持
Opaleye Management Inc. 2.23M $7.17M 1.27% 增持
Palo Alto Investors LP 1.79M $5.63M 0.87% 持有
Siren, L.L.C. 1.73M $5.43M 0.24% 持有
Geode Capital Management 1.71M $5.37M 0.00% 增持
STEMPOINT CAPITAL LP 1.70M $5.35M 1.54% 增持
Alyeska Investment Group, L.P. 1.52M $4.76M 0.02% 新进
STATE STREET CORP 1.44M $4.53M 0.00% 增持
RTW INVESTMENTS, LP 978.31K $3.07M 0.05% 持有
Kynam Capital Management, LP 847.37K $2.66M 0.16% 持有
Ikarian Capital, LLC 676.61K $2.12M 0.39% 持有
JACOBS LEVY EQUITY MANAGEMENT, INC 662.98K $2.08M 0.01% 减持
Northern Trust Corp 630.05K $1.98M 0.00% 增持
JPMorgan Chase & Co 618.13K $1.94M 0.00% 减持

Q3 2024 — 25 家基金

基金股数金额组合权重变化
T. Rowe Price Investment Management, Inc. 10.43M $51.43M 0.03% 增持
AyurMaya Capital Management Company, LP 9.33M $46.02M 28.81% 持有
BlackRock Inc 5.98M $29.49M 0.00% 新进
MILLENNIUM MANAGEMENT LLC 5.49M $27.05M 0.05% 增持
Millennium Management 5.49M $27.05M 0.01% 增持
Vanguard Group 4.07M $20.05M 0.00% 减持
ORBIMED ADVISORS LLC 4.00M $19.73M 0.38% 持有
venBio Partners LLC 3.85M $18.99M 9.77% 持有
GENERAL ATLANTIC, L.P. 2.89M $14.25M 0.41% 持有
Blue Owl Capital Holdings LP 2.79M $13.77M 2.66% 减持
Samsara BioCapital, LLC 2.52M $12.44M 2.39% 持有
Opaleye Management Inc. 1.89M $9.34M 1.57% 增持
Palo Alto Investors LP 1.79M $8.84M 1.15% 增持
Morgan Stanley 1.79M $8.81M 0.00% 增持
Siren, L.L.C. 1.73M $8.53M 0.43% 新进
Geode Capital Management 1.65M $8.14M 0.00% 增持
JACOBS LEVY EQUITY MANAGEMENT, INC 1.33M $6.54M 0.03% 减持
STEMPOINT CAPITAL LP 1.32M $6.50M 2.58% 新进
STATE STREET CORP 1.27M $6.28M 0.00% 增持
RTW INVESTMENTS, LP 978.31K $4.82M 0.07% 持有
JPMorgan Chase & Co 850.66K $4.19M 0.00% 减持
Kynam Capital Management, LP 847.37K $4.18M 0.32% 增持
Ikarian Capital, LLC 677.07K $3.34M 0.67% 减持
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 609.68K $3.01M 0.00% 增持
Charles Schwab Investment Management 609.68K $3.01M 0.00% 增持

Q2 2024 — 25 家基金

基金股数金额组合权重变化
AyurMaya Capital Management Company, LP 9.33M $41.17M 22.52% 持有
Vanguard Group 4.74M $20.92M 0.00% 减持
Fidelity Management & Research (FMR) 4.71M $20.79M 0.00% 减持
MILLENNIUM MANAGEMENT LLC 4.64M $20.47M 0.04% 增持
Millennium Management 4.64M $20.47M 0.01% 增持
ORBIMED ADVISORS LLC 4.00M $17.65M 0.36% 持有
venBio Partners LLC 3.85M $16.99M 7.34% 持有
T. Rowe Price Investment Management, Inc. 3.35M $14.78M 0.01% 增持
Blue Owl Capital Holdings LP 2.93M $12.90M 3.59% 增持
GENERAL ATLANTIC, L.P. 2.89M $12.74M 0.40% 持有
JPMorgan Chase & Co 2.60M $11.46M 0.00% 持有
Samsara BioCapital, LLC 2.52M $11.13M 2.33% 持有
Artal Group S.A. 2.02M $8.91M 0.23% 减持
Woodline Partners LP 1.98M $8.75M 0.08% 增持
Palo Alto Investors LP 1.72M $7.56M 0.88% 持有
Opaleye Management Inc. 1.58M $6.97M 1.62% 持有
JACOBS LEVY EQUITY MANAGEMENT, INC 1.48M $6.53M 0.03% 增持
Ikarian Capital, LLC 1.48M $6.51M 1.75% 减持
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.40M $6.17M 0.01% 减持
Geode Capital Management 1.26M $5.57M 0.00% 增持
Morgan Stanley 1.25M $5.52M 0.00% 增持
STATE STREET CORP 1.16M $5.10M 0.00% 增持
RTW INVESTMENTS, LP 978.31K $4.31M 0.07% 持有
Kynam Capital Management, LP 831.31K $3.67M 0.28% 增持
Goldman Sachs Group 799.63K $3.53M 0.00% 增持

Q1 2024 — 25 家基金

基金股数金额组合权重变化
AyurMaya Capital Management Company, LP 9.33M $63.01M 100.00% 持有
Fidelity Management & Research (FMR) 7.08M $47.78M 0.00% 减持
Vanguard Group 6.24M $42.10M 0.00% 增持
MILLENNIUM MANAGEMENT LLC 4.01M $27.09M 0.05% 新进
Millennium Management 4.01M $27.09M 0.01% 新进
ORBIMED ADVISORS LLC 4.00M $27.01M 0.51% 持有
venBio Partners LLC 3.85M $26.00M 9.22% 持有
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.28M $22.14M 0.04% 增持
GENERAL ATLANTIC, L.P. 2.89M $19.51M 0.45% 持有
Blue Owl Capital Holdings LP 2.83M $19.08M 3.81% 增持
JPMorgan Chase & Co 2.59M $17.49M 0.00% 减持
Samsara BioCapital, LLC 2.52M $17.03M 2.63% 持有
Artal Group S.A. 2.41M $16.23M 0.42% 减持
T. Rowe Price Investment Management, Inc. 2.12M $14.31M 0.01% 新进
Franklin Resources 2.04M $13.80M 0.01% 增持
Palo Alto Investors LP 1.72M $11.58M 1.31% 新进
Opaleye Management Inc. 1.58M $10.66M 2.34% 减持
Ikarian Capital, LLC 1.56M $10.56M 2.19% 增持
Geode Capital Management 1.23M $8.30M 0.00% 增持
STATE STREET CORP 1.13M $7.62M 0.00% 增持
Woodline Partners LP 1.02M $6.89M 0.06% 增持
RTW INVESTMENTS, LP 978.31K $6.60M 0.10% 持有
Venrock Adviser, LLC 937.11K $6.33M 0.30% 持有
Goldman Sachs Group 755.90K $5.10M 0.00% 减持
STEMPOINT CAPITAL LP 714.77K $4.82M 2.65% 增持

查看全部 222 家持有基金 →

新建仓(最新)

本季度没有基金新建该仓位。

完全清仓(较上季)

本季度没有被追踪基金完全清仓。

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
OSAIC HOLDINGS, INC. 282 — — — — — 377 1.45K —
IFP Advisors, Inc 3 — — — — — — — —
AyurMaya Capital Management Company, LP — 9.33M 9.33M 9.33M 9.33M 9.33M 9.33M 9.33M —
Fidelity Management & Research (FMR) — 4.98K 164.31K 117.75K 4.71M 7.08M 8.82M 8.96M 7.46M
ORBIMED ADVISORS LLC — 4.00M 4.00M 4.00M 4.00M 4.00M 4.00M 5.33M —
T. Rowe Price Investment Management, Inc. — 4.65M 12.87M 10.43M 3.35M 2.12M — — —
Vanguard Group — 4.08M 4.08M 4.07M 4.74M 6.24M 6.16M 3.19M 3.07M
Opaleye Management Inc. — 1.61M 2.23M 1.89M 1.58M 1.58M 4.15M 4.15M —
venBio Partners LLC — 3.81M 3.81M 3.85M 3.85M 3.85M 3.85M 3.85M —
JPMorgan Chase & Co — 590.85K 618.13K 850.66K 2.60M 2.59M 3.19M 3.16M 3.70M
BlackRock Inc — 5.81M 6.02M 5.98M — — — — —
GENERAL ATLANTIC, L.P. — 2.70M 2.70M 2.89M 2.89M 2.89M 2.89M 2.89M —
MILLENNIUM MANAGEMENT LLC — 149.30K 4.71M 5.49M 4.64M 4.01M — 34.20K —
Artal Group S.A. — — — — 2.02M 2.41M 3.04M 2.47M —
TANG CAPITAL MANAGEMENT LLC — 9.82M — — — — — — —
Samsara BioCapital, LLC — 2.52M 2.52M 2.52M 2.52M 2.52M 2.52M 2.38M —
ADAGE CAPITAL PARTNERS GP, L.L.C. — — 450.00K 545.48K 1.40M 3.28M 180.00K 100.00K —
STATE STREET CORP — 1.42M 1.44M 1.27M 1.16M 1.13M 664.94K 1.98M —
Blue Owl Capital Holdings LP — — 2.78M 2.79M 2.93M 2.83M 2.29M — —
Goldman Sachs Group — 351.41K 569.91K 521.92K 799.63K 755.90K 1.12M 1.78M 310.00K

下载持有人名单 (CSV)

常见问题

Which funds hold SLRN?

222 funds have reported positions in SLRN across five years of 13F filings; the sum of their latest reported stakes is $342.97M.

Who are the top institutional holders of SLRN?

The largest 13F holders are TANG CAPITAL MANAGEMENT LLC, AyurMaya Capital Management Company, LP, BlackRock Inc, EcoR1 Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of ACELYRIN INC?

The major shareholders of ACELYRIN INC (SLRN) by reported 13F value are TANG CAPITAL MANAGEMENT LLC, AyurMaya Capital Management Company, LP, BlackRock Inc, EcoR1 Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, among 222 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 SLRN」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/SLRN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →